Eli Lilly & Co
LLY· NYSE
Released Feb 6, 2024, before the open
10-K filed Feb 21, 2024, 52 days after period end · 0000059478-24-000065
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $9.35B | $7.30B | $8.00B | $7.44B |
| Net Income | $2.19B |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.94B |
| $1.73B |
| $2.12B |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.